Patent · US Active

Adenosine deaminase anticancer therapy

US8741283B2 · kind B2 · utility

6Cited by

25References

19Claims

0Family size

Assignee

Sigma-Tau Rare Diseases, S.A. · PT

Inventors

David Filpula · Gaithersburg, US
Puja Sapra · Edison, US

Key dates

Filing date	Apr 18, 2008
Grant date	Jun 3, 2014
Priority date	—
Expiry date	Sep 6, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y305/04004
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

What is provided is a method of treating a patient having a tumor comprising administering an effective amount of adenosine deaminase, preferably polyalkylene oxide conjugated, to a patient in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.